Nkgen Biotech Inc (NKGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NKGN | AZN | AMGN | GILD | VRTX |
| Company | Nkgen Biotech Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0600 | 92.52 | 328.09 | 124.17 | 460.44 |
| High | 0.0600 | 93.10 | 333.67 | 127.41 | 461.49 |
| Low | 0.0600 | 92.37 | 328.07 | 124.00 | 458.80 |
| Latest | 0.0600 | 92.60 | 331.83 | 126.55 | 459.12 |
| Change | +0.0100 | +1.05 | +0.44 | +2.39 | -1.19 |
| % Change | +20.00% | +1.15% | +0.13% | +1.92% | -0.26% |
| Volume | 3,203 | 477,176 | 100,529 | 487,938 | 88,216 |
| 20-Day Average Volume | 6,925 | 5,588,706 | 3,135,063 | 7,160,696 | 1,441,521 |
| Previous Close | 0.0500 | 91.55 | 331.39 | 124.16 | 460.31 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0371 | 91.14 | 330.09 | 122.98 | 446.80 |
| 20-Day Raw Stochastic | 74.36% | 72.39% | 59.05% | 84.56% | 90.32% |
| 20-Day Relative Strength | 54.47 | 60.81 | 56.46 | 57.81 | 60.91 |
| Weighted Alpha | -47.35 | +43.26 | +27.15 | +33.82 | +13.16 |
| Today's Opinion | 40% Sell | 100% Buy | 88% Buy | 96% Buy | 72% Buy |
| Previous Opinion | 40% Sell | 100% Buy | 88% Buy | 88% Buy | 72% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 12/15/25 | +1.49% since 12/16/25 | +1.75% since 12/16/25 | +6.60% since 12/16/25 | +1.09% since 12/16/25 |
| Low | 0.0370 on 12/17/25 | 89.85 on 12/17/25 | 321.91 on 12/18/25 | 118.57 on 12/17/25 | 445.41 on 12/18/25 |
| High | 0.0600 on 12/18/25 | 93.09 on 12/23/25 | 333.42 on 12/23/25 | 127.41 on 12/23/25 | 461.09 on 12/23/25 |
| 1-Month | |||||
| %Chg | +138.10% since 11/20/25 | +1.88% since 11/21/25 | -1.51% since 11/21/25 | -0.02% since 11/21/25 | +7.77% since 11/21/25 |
| Low | 0.0310 on 11/25/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 423.45 on 12/01/25 |
| High | 0.0600 on 12/18/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.25 on 11/24/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -54.55% since 09/22/25 | +22.03% since 09/23/25 | +15.92% since 09/23/25 | +10.68% since 09/23/25 | +21.13% since 09/23/25 |
| Low | 0.0002 on 10/06/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 0.3299 on 10/13/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | -80.00% since 06/20/25 | +31.24% since 06/23/25 | +22.03% since 06/23/25 | +19.24% since 06/23/25 | +3.70% since 06/23/25 |
| Low | 0.0002 on 10/06/25 | 68.61 on 07/21/25 | 269.01 on 06/24/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 0.3800 on 07/01/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,219 | 283,937,952 | 178,447,232 | 154,042,848 | 116,789,392 |
| Shares Outstanding, K | 124,377 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -44,290,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -29,410,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.98 | 0.31 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.95 on 10/07/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/03/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.99 | 14.97 | 15.18 | 29.80 |